Lifeon Pharmaceutical: The application for the listing of the chemical raw material drug Procaine Hydrochloride has been approved
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Lifeon Pharmaceutical announced that the company has received the "Approval Notice for the Market Application of Chemical Raw Materials" for Procaine Hydrochloride issued by the National Medical Products Administration. The announcement shows that Procaine Hydrochloride is a potent ester local anesthetic, and its formulation, Procaine Hydrochloride eye drops, is primarily used clinically for surface anesthesia in ophthalmology, making it a fast-acting local anesthetic
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments